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More than 5 million Americans suffer from diabetic disease. Type I or insulin
dependent diabetes can be controlled by continuous administration of insulin, but Type IT
or non-insulin dependent diabetes can not. Noticeably, vanadium, a widely distributed
trace element, was found to normalize blood glucose levels in stteptozotocin-treated rats
(STZ-rats ) which exhibit symptoms of both Type I and Type II diabetes (1). Drinking
water containing"" 0.7 mg/ml of vanadate or 0.2 mg/ml of vanadyl (vanadium in reduced
fonn) decreased blood glucose levels of the streptozotocin-treated rats without affecting that
of nonnal rats. Various laboratories documented that vanadate has insulin-like effects in
vivo and in vitro as well as inhibiting (Na+-K+)-ATPase. However, the concentrations
of vanadate required to inhibit glucose synthesis in isolated cells were much higher (mM
vs. JlM) than those observed in the intact rats. Thus, specific actions of vanadate to lower
blood glucose levels in diabetic animals might be the consequence of long-tenn adaptation
in gene expression. A chimeric gene construct containing the 1000 bp 5'-promoter region
of the rat pyruvate kinase gene with fIrefly luciferase was made and ttansfected into
primary culture of rat hepatocytes (2). The results of preliminary studies showed that both
insulin and vanadate regulate the gene expression of L-type pyruvate kinase (L-PK).
However, it is not known whether insulin and vanadate regulate the gene expression
through the same region(s) in the L-PK promoter. The present research is to address the
effects of glucose, insulin and vanadate on gene expression of L-type pyruvate kinase by





Vanadium was discovered by the Swedish scientist N.G.SefstrOn in 1830 and was
named after the Scandinavian goddess "Freya Vanadis". Gamyee and Larmuth were
perhaps the fust workers to study the biological properties of this element in frog heart in
1876 (3). Although vanadium is a trace element, it is widely distributed in nature and
exists in almost all living things. "fhe concentration of vanadium in sea water is about 5 x
10-8 M. The amount of dietary vanadium required for nonna! growth in rats is about 100
ppb or 2 nM and nonna! tissue concentrations are about 0.1-0.7 nmoVg wet weight Most
tissues of higher animals contain intracellular vanadium at a concentration of 0.1-1.0 JlM
except that within the blood cells of the tunicate Ascidia nigra, the concentration of
vanadium is of the order 1 M. No other known organisms have so efficient a mechanism
for vanadium accumulation (1, 4).
Vanadium has also been recognized as an essential nutrient in higher animals. Most
available studies support the view that vanadium in the diet is essential for growth of
various organisms. Even though vanadium compounds could be toxic to man and animals
(actually, vanadium is relatively non-toxic to human, severely toxic to chicks), removal of
the minute quantities normally present in the diet leads to deficiency disorders in
experimental animals. Rats given a low vanadium diet exhibited reduced body growth and
increased iron in blood and bone. Vanadium deficiency in chicks could lead to
abnormalities in bone and increased plasma cholesterol levels, impaired reproductive
perfonnance and severe disorganization of the cells of the epiphysis with subsequent bone
marrow fonnation. Cholesterol synthesis and feather growth in chicks are influenced by
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vanadium. Lipid metabolism and red cell concentration in blood are also influenced by the
ion in rats (1, 3, 5-7). These studies show that vanadium may play an role in
developmental physiological states, but the biological basis for its role is still unknown.
Vanadium Cbemist[y
Vanadium (V), mol. wt. 50.9, is an element of the transition series. Its oxidation
states of biological interest are +3, +4, and +5. The valence states change readily with
environmental conditions. V+3 and y+4 is stable only in acidic solution ( pH < 2 ) and in
the absence of oxygen. They will be rapidly oxidized by dissolved oxygen at physiological
pH. V+3 and V+4 interconvert readily under physiological conditions. Below pH 3, V+4
exists as the blue vanadyl cation V02+ which has an unpaired electron and is paramagnetic
and hence can be detected by electron spin resonance spectroscopy (ESR). V+5 is a
powerful oxidant in acid solution or even at pH 7. y+4 is the major form present in
mammals, but tunicates have also been found to contain vanadium V+3. Vanadium can
fonn polynuclear species with phosphate. The close similarity of vanadate to phosphate
gives rise to much of its biological interest (6, 8).
Vanadate - Inhibitor of ATPase
In the last two decades, intensively research on the biological actions of vanadium
was due to the fact that vanadate inhibited (Na+-K+)-ATPase. This property was first
found from "Sigma Grade" ATP. In 1977 Cantley and co-workers (9) successfully
purified from "Sigma Grade" ATP a potent inhibitor of (Na+-K+)-ATPase which was
found to be identical with sodium orthovanadate (Na3Y04, vanadate is vanadium in +5
oxidation state, y+5) and then vanadate was confirmed to be present in commercially
available ATP prepared from equine and rabbit muscle but not in ATP isolated from yeast
(10). 40 oM Na3V04 caused 50% inhibition of (Na+-K+)-ATPase. The inhibition could
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be completely reversed by norepinephrine and was unaffected by EDTA or dithiothreitol at
millimolar concentrations (9).
After vanadium inhibition was found as an impurity of ATP, studies on both the
physiological and biochemical effects of vanadate were carried out and have revealed a
wide range of its actions. Particular interest of vanadium is its apparently selective
inhibition on some ATPases, which has led to its use as a selective probe. It inhibits
several enzymes, which hydrolyze phosphate ester bonds, such as alkaline phosphatase
(11), phosphofructokinase (12) and adenylate kinase (13). Enzymes known to be either
inhibited or activated by vanadium are listed in Table 2-1 (6), their mechanisms of actions,
where known, frequently include covalent phosphoenzyme intennediates.
In order to understand the ability of ATPase inhibition of vanadium, it is helpful to
know the (Na+-K+)-ATPase system. The (Na+-K+)-ATPase of plasma membrane is a
active transport protein of cells. It consists of two types of subunits: A 110-kD
nonglycosylated a subunit that contains the enzyme's catalytic activity and ion-binding








The putative dimeric structure of the (Na+·K+).ATPase (p494 in
reference 14).
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It pumps Na+ out of and K+ into the cell with the concomitant hydrolysis of intracellular
ATP to maintain water osmotic pressure of animal cells. The ATP hydrolysis drives the
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A scheme for the transport of Na+ and K+ by (Na+-K+)-ATPase (p495
in reference 13).
The protein is phosphorylated by ATP on an Asp residue to fonn a highly reactive aspartyl
phosphate intermediate. The enzyme has two confonnational states, El and E2, which
have different tertiary structures, catalytic activities and ligand specificities_ El has an
inward-facing high affinity Na+-binding site and reacts with ATP to form the activated
product EI--P only when Na+ is bound. E2-P has an outward-facing high affinity K+-
binding site and hydrolyzes to fonn Pi + E2 only when K+ is bound.
Inhibition of (Na+-K+)-ATPase by vanadium was identified as vanadate (+5
oxidation state of vanadium) (9). Vanadate (V04+3,an analog of phosphate) competes
with phosphate by binding to the site where phosphate is released during turnover (15). It
is possible that vanadate may combine with a phosphate site to cause inhibition of the
pump. High effective inhibition of vanadate is thought to occur in that (11) pentavalent
Table 2-1
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Activated
U-uridine: a-glyceraldehyde 3-phosphatc; E-V indicates acovalent link
between enzyme aDd vanadium. Mitochondri31 H+·ATPase and ascites
plasma membrane Ca2 + -ATPase arc not inhibited by vanadate.
presumably because they do not generate E-P intermediates.
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vanadium can easily adopt a stable trigonal bipymmidal structure. This structure resembles
the transition state of phosphate during reaction. Vanadate binds to the phosphorylation
site of the (Na+-K+)-ATPase during reactions from the cytoplasmic side of the plasma
membrane. It should be noted that maximal ouabain binding was achieved with JlM
concentration of vanadate, whereas mM concentrations of Pi (inorganic phosphate) were
needed for the same effect (16). Several reports indicated that vanadate binding is
facilitated by internal Mg2+, and it appears to lock the enzyme in the E2 state which binds
K+. Similar inhibition of Ca-ATPase by vanadate has been demonstrated in various tissues
(17-20). The dissociation rates of vanadate from ATPases differ considerably (17, 20).
Ethylenediamine tetraacetic acid (EDTA) rather than ethylene glycol-bis (Ji-aminoethyl
ether) N, N, N', N',-tetraacetic acid (EGTA) and trans-I, 2-diaminocyclohexane-N, N,
N', N' -tetraacetic acid (COTA) can reverse the inhibition. Inhibition by vanadate is
dependent on pH.
Cantley et al (14, 21) have demonstrated that vanadate inhibits the sodium pump
from the cytoplasmic site. Thus, vanadate has to pass through the cell membrane to get
into these sites. In certain cells, such as erythrocytes or in bull frog corneas vanadate is
transported into the cells via the anion carrier system. The anion flux inhibitors SITS (4-
acetoamido-4'-isothiocyanatostilben-2-2-disulfonate) or DIDS ( 4, 4'- diisothio-
cyanostilbene-2-2-disulfomic acid) prevent vanadate penetration of the cell membrane.
However, in cardiac cells vanadate is apparently transported through the cell membrane by
a different non-energy-dependent carrier system. Vanadate often seems to be reduced to
vanadyl ions (V02+) when it binds to proteins inside cells. "Vanadyl complex" (vanadium
in reduced fonn) appeared to be the weakest of all analogs in either inhibiting the (Na+-
K+)-ATPase or producing pharmacological actions (22), Vanadyl ions have different
effects from vanadate. v02+ is a powerful inhibitor of alkaline phosphatase, but has no
effect on the (Na+-K+)-ATPase, whereas other vanadate compounds were approximately
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equal in potency. This may partially explained why vanadate is not a more potent inhibitor
of transport in whole cells. The question of whether cation transport may be regulated in
vivo by an oxidation-reduction change in vanadium is still obscure. In the plasma, Donna!
oxygen pressure keeps it in an oxidized state as vanadate, which is a more potent inhibitor
of the pump (2). Vanadium regulates the (Na+-K+)-ATPase associated with oxidation-
reduction states (21).
Not only vanadium oxidation states but its monoanion and polynuclear complexes
can also influence biological functions. For instance, adenylate kinase is inhibited more
strongly by oligomeric vanadate than by the monoanion (12). X-ray diffraction studies
suggest that the oligomer sits across the phosphate-binding portions of both the ATP and
the AMP sites on the enzyme (23). When the concentration of HV042- is above 10-4 M, it
will fonn polynuclear complexes (24).
Curiously, in addition to vanadate as a potent ATPase inhibitor, opposite effects of
vanadate are also documented. For example, vanadate activates rather than inhibits
adenylate cyclase. Vanadate induced vasoconstriction is not associated with attenuation of
sodium pump activity (3). On the other hand, vanadium compounds have been shown to
inhibit cholesterol synthesis, enhance phospholipid oxidation, inhibit liver ATP production
(4) and lower hepatic coenzyme A levels both necessary for sterol production.
Furthermore, vanadate inhibits multifunctional glucose-6-phosphatase as well as several
other enzyme systems involved in carbohydrate metabolism, which suggests that vanadium
might well affect the metabolism of another energy source, glucose (2). Vanadium in the
fonn of sodium orthovanadate, sodium metavanadate and/or ammonium vanadate has been
employed in studies of these effects.
Insulin-like effects of vanadate
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reduced intracellularly to vanadyl (V02+) ions (+4 oxidation state) and vanadyl is a
relatively ineffective inhibitor of this enzyme_
Insulin-like effects of vanadate influence glucose metabolism in various tissues -
adipocytes, hepatocytes, diaphragm and intestine. Both VOS04-2H20 and Na3V03,
which stimulate the oxidation of glucose _14C to 14C02, is concentration dependent and is
additive (4). Like insulin, vanadate also augments 125I-IGF-II (type II insulin-like growth
factor) binding on the cell surface of rat adipocytes in a dose-dependent fashion (32). It
would appear that changes in (Na+-K+)-ATPase are not decisive for effecting change in
IOF-II binding since ouabain and amiloride, other inhibitors of this enzyme (33), did not
influence 125I-IGF-II binding. Morever, vanadate increases fructose-2,6-biphosphatase
levels in isolated hepatocytes from non-diabetic rats and counteracts the effects of glucagon
(opposite effector of insulin) on cAMP levels and cAMP-dependent protein kinase activity
(35). The ion affects fructose-2,6-biphosphatase concentration in a time- and dose-
dependent manner (34). Therefore, vanadate has insulin-like effects on the glucose
metabolism pathway in rat hepatocytes. Incubation of isolated rat adipocytes with vanadate
elicited an insulin-like stimulation of the rate of glucose oxidation and 2-deoxyglucose
transport. The maximal 6- to 12-fold stimulation of the transport observed in vanadate-
treated adipocytes was equivalent to that produced by a maximally activating concentration
of insulin (36). Vanadate and insulin have additive properties at their submaximal
concentrations in these cases.
These observations suggest that vanadate acts via a pathway similar to that of
insulin. Cellular insulin action is initiated by the interaction of the honnone with its specific
cell surface receptors. Insulin receptor is embraced in the plasma membrane and consists
of two a-subunits (MW -135,00 each) and two ~-subunits (MW -95,000 each). The
major portion of a-subunit faces to the extracellular space and f3-subunit is exposed to
intracellular space. It is now known that the (i-subunit of the insulin receptor is a tyrosine
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kinase whose activity is stimulated by insulin (37 t 38). Insulin stimulates
autophosphorylation of the ~subunit and thereby activates its tyrosine kinase activity (39,
40). Upon insulin binding, tyrosine residue will be phosphorylated. This phosphorylation
initiates a cascade of cellular phosphorylation reactions which result in multiple enzymatic
processes. Vanadate may enhanced the degree of phosphorylation of the ~-subunit
selectively on tyrosine residues (41). This may be brought about by activation of a specific
tyrosyl-protein kinase or inhibition of a phosphatase. The effect of vanadate, like that of
insulin, was reversed by incubation with epinephrine (41, 42).
Studies (81) showed that the concentrations of vanadate needed to inhibit glucose
synthesis were 10 to 100 -fold higher than those observed in the intact rat responding to the
ion, and that the specificity for diabetic animals was not explained by studies with isolated
cells. Thus, it was proposed that specific actions of vanadate to lower glucose
concentrations in diabetic animals was also the consequence of long-term actions of
vanadate on those enzyme gene expressions. Studies documented that insulin regulates
gene expressions of albumin, aldolase B, phosphoenolpyruvate carboxykinase (PEPCK)
and L-type pyruvate kinase (L-PK), and that vanadate, like insulin, inhibits gene
expression of phosphoenolpyruvate carboxykinase and induces mRNA level of L-type
pyruvate kinase (43, 44). Phosphoenolpyruvate carboxykinase gene was contrary
regulated by insulin and cAMP (second messenger of glucagon) (45).
However, in isolated hepatocytes from healthy (46) or diabetic (47) rats, vanadate
produces the inactivation and phosphorylation of glycogen synthase and the activation of
glycogen phosphorylase, effects opposite to those of insulin and similar to the effects of the
glucagon. Second, the effect of vanadate on glucose transport is independent of the insulin
receptor (48). Induction of a post-receptor defect (which may be a decrease in the total
number of cellular glucose transporters) by prolonged expose to insulin decreases the
potency of a maximally effective concentration of vanadate. The findings demonstrate that
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vanadate stimulates glucose transport by an effect at a level distal to the insulin receptor
(48). Third, the insulin-like effect of vanadate on lipolysis in rat adipocytes is not
accompanied by an insulin-like effect on tyrosine phosphorylation (49). Bosch (50)
reported that in the hepatocytes vanadate exerts opposite effects of that in the adipocytes
and skeletal muscle, where vanadate had an insulin-like action. In the study of PEPCK
(43), vanadate inhibition of gene expression was similar to that required for the vanadate-
mediated activation of the insulin receptor tyrosine kinase, but a comparison of the
inhibitory effects of insulin and vanadate in this system indicated a major difference in the
site of action of these two compounds. Finally, the diabetes disease has two clinical
manifestation: insulin dependent (type I which is irreversible insulin defect) and non-insulin
dependent (type II which is insulin resistant). The molecular basis of type II diabetes is
still poorly understood despite intensive research. In an animal model, STZ-rats have both
type I and type II diabetes symptoms, but vanadate can nonnalized their glucose levels to
control healthy value.
The discrete insulin-like actions of vanadate on carbohydrate metabolism challenge
us to further explore the insulin-like mechanism of vanadate by employing L-type pyruvate
kinase which has been studied for a long time.
L-type Pyruyate Kinase <L-PK)
The concentration of blood glucose in mammals is tightly regulated both by
production of glucose by liver and uptake by muscle and adipose. The pathways of
glycolysis and gluconeogenesis share common enzymes except some key enzymes which
are unique to each physiologically irreversible steps. The key enzymes include: pyruvate
carboxylase, phosphoenolpyruvate carboxykinase (PEPCK), phosphofructokinase (PFK),
fructose-l,6-biphosphatase (FBP), and glucose-6-phosphatase (G6P), etc. Pyruvate
kinase (PK) is one of the key enzymes. It catalyzes the following reaction:
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Pyruvate kinase
Phosphoenolpyruvate + MgADP > Pyruvate + MgATP
M g2+, K+
Insulin and insulin counter-regulatory honnones such as glucagon and epinephrine regulate
hepatic glucose production. Glucagon and epinephrine enhance glucose production by
increasing the rate of glycogen breakdown and de novo glucose synthesis
(gluconeogenesis). Insulin, which lowers blood sugar and decreases glucose output by the
liver, counteracts the actions of glucagon. Genes for PK, PEPCK and GK (glucose
kinase) have been isolated and studied. Administering insulin to diabetic animal models
causes rapid changes in the phosphorylation state of several these enzymes and restores
their gene expression to nonnal. The enzyme pyruvate kinase exemplifies all levels of
regulation by honnones known to influence hepatic carbohydrate metabolism and reflect the
insulin-like response of vanadate (51).
Pyruvate kinase has four isoenzymes which are named M1, M2, L and R (52, 53).
Mt-type is found in adult skeletal muscle and is a major isozyme in heart and brain. M2-
type appears to be a primordial fonn of the enzyme and is predominant in the internal
organs (such as spleen and lung). R-type is found in erythrocytes. L-type is the major
isozyme of adult liver and the only isozyme found in the parenchymal cells of this tissue in
adults (54, 55). The organizations and expressions of pyruvate kinase isozyme genes are
interesting. Genetic studies showed that the M1- and M2-types of rat pyruvate kinase are
derived from a signal gene, so do L- and R-types. Mt- and M2-types are produced from
the same gene by alternative RNA splicing (56). L- and R-type isozymes of rat pyruvate
kinase are generated from a single gene by use of different promoters (53).
A rat haploid genome contains a single L-PK gene and the gene is composed of 12
exons and 11 introns with a length of about 9.3 kilobase pairs. The frrst (exon R) and
second (exon L) exons encode the 5'-tenninal sequences specific for the R- and L-type
Pyruvate kinase L gene
14
















A scheme of expression of the pyruvate kinase L gene. Exons are
numbered. CAAT, CAT box; TATA, TATA box; poly(A), polyadenylation signal;
L-PK, L-type pyruvate kinase; R-PK, R-type pyruvate kinase. (scheme presented
by Villar-Palasi, C. in reference 53)
The last exon contains the entire 3'-untranslated region which has several putative
polyadenylation signals. Sequences downstream from the poly(A)+ signal are essential for
the fonnation of its mature mRNA (57). Multiple mRNA species for the L-type might be
generated by alternative use of these signals. The R-type uses only the first poly(A)+
signal. There is 16-nucleotide mRNA cap site for the L-type within the PK gene. The R-
type might have multiple cap sites within the PK gene. The L-type has a canonical TATA
box in the upstream sequence of exon L, whereas one (or several) CAT box(S) for the R-
type (53).
A total sequence of a 13,021 base-pair (bp) genomic fragment containing the rat L-
PK was sequenced by Unite (58). This fragment includes 8360 bp of the L-PK gene, plus
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3193 bp of the 5'-flanking and 1468 bp of the 3'-flanking regions. L-PK gene exhibits a
fully conserved exon-intron structure. At position -776 and +7821, a TOnCf sequence
that is present in the glucocorticoid receptor binding site for DNA was found (59). The
sequence, 5'-CITACCfCAGT G-3' at position -2338, and 5'-CITACGTCfGAG-3' at
position +5788 were found homologous to the cAMP regulatory elements described in the
phosphoenolpyruvate carboxykinase gene (60).
Studies by Dynan and Maniatis (61, 62) indicated that the control of gene
expressions are achieved through the interactions between cis-acting DNA elements and
trans-acting proteins that bind to these DNA sequences. 5'-flanking region contains cis-
acting DNA elements responsible for tissue-specific expression (63-65) and honnonal
regulation (60, 66).
Transient DNA transfer experiments with L-PK/CAT (chloramphenicol
acetyltransferase) fusion genes performed by Yamada (67) showed that three positive
regulatory regions are necessary for expression of L-PK in adult rat hepatocytes by
functional analyses of a 5'- and internal deletion constructs of the fusion genes. These
regions are: -76 to -94, -126 to -149, and -150 to -170. Vanlont (68) reported that region
-96 to -66 ( with respect to the cap site) binds a liver-specific protein.
Decans (69) developed a model of adult rat hepatocytes in primary culture, whose
behavior is identical to that in vivo, to study the action of different effectors on the
expression of L-PK gene. In these cells, the genes expressed only when glucose and
insulin are present together, each of them being inactive by itself. In vivo studies have
shown that the expression of L-PK gene is regulated by honnones and carbohydrates at
both transcriptional and post-transcriptional levels. The major negative effector is glucagon
and its second messenger cAMP, the major positive effectors are carbohydrates in the
presence of insulin, thyroid honnones and glucocorticoids which appear to play a
pennissive role (70, 71). Like insulin in primary culture of adult rat hepatocytes, vanadate
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stimulates L-PK gene expression in the presence of glucose. Similar results were obtained
on glucokinase gene expression (44). However, Decaux (72) indicated that transcription of
the albumin gene is active in the presence of insulin alone, with or without glucose,
whereas transcription of the aldolase B is stimulated by glucose and insulin together, but
not by insulin or glucose alone.
Recently, Towle et al (73) constructed a series of chimeric genes containing
different deletion of 5' -flanking sequence of rat L-PK fused to CAT gene and transfected
these genes into primary hepatocytes. Sequence from -4300 to +12 of L-PK gene directed
an increase in CAT activity when hepatocytes were switched from media containing 10 mM
lactate to 25 mM glucose. Carbohydrate regulation of the L-PK promoter was retained
with 5'-deletion to -197, but constructs deleted to -96 were completely unresponsive.
Therefore, a carbohydrate response element (eRE) is located between -197 to -96 of the L-
PK gene, and it has the enhancer-like properties of functioning in concert with a
heterologous promoter and functioning in an orientation-independent manner. The
transfected gene was also regulated by insulin and glucagon in a pattern similar to that seen
for the endogenous L-PK gene, suggesting that control of L-PK promoter activity was
responsible for carbohydrate-mediated changes in L-PK mRNA transcription.
These observations might suggest that insulin and/or vanadate (and/or glucagon)
may affect gene expression indirectly by altering rates of carbohydrate metabolism and thus
influencing the activity of the same nuclear factors affected by glucose. Alternatively,
insulin and/or vanadate (and/or glucagon) affect nuclear events more directly, possibly via
phosphorylation schemes resulting in altered transcription factor activity to what had been
previously descried for glucagon action on the somatostatin gene by Yamada (67).
Apparently, vanadate mimicking insulin effects is not always exactly the same as
that elicited by insulin. Since a gene construct (pOL-Reg5) containing a 1000 bp 5'-region
(RegS) of the L-PK promoter with the fIrefly luciferase gene was responsive to glucose,
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insulin and vanadate by yet unknown mechanism., in which insulin and vanadate seemed to
act directly on the gene (81) rather than playing a upennissive" role. The present research
involves constructing chimeric genes, which contain a series of L-PK promoters with
deletions, to detect the sequences responsive to insulin and vanadate. If vanadate indeed




Plasmid Construction and Isolation
Seven fragments (designated E, F, G, H, I, J and K) represented on a serial
deletions of the complete promoter end of the L-PK gene were obtained by polymerase
chain reaction (PCR) using synthetic oligonucleotides which were about 28-base long and
have appropriate restriction enzyme sequences flanking the promoter regions of interest as
peR primers. K was made by directly priming the corresponding primer to rat genomic
DNA, and E through J were from Reg5, which was studied by Mr. Chris Otiko (2), by
peR using their corresponding prime respectively. Thus, each fragment has Hind III
restriction site at 5'-end and Bgi II restriction site at 3'-end.
The above work was done by Raul Espinosa-Nava (unpublished). The fragments
from peR were respectively inserted into the Hind III and Bg/ II sites of pGL2-Basic
(Promega) vector, containing a luciferase marker, by fust digesting the vector with Hind ITI
and Bgl n restriction enzymes followed by ligation with T41igase to construct a series of
chimeric genes. The inserted DNA fragments were oriented in pGL2-Basic vector such
that the luciferase gene is under control of the L-PK promoter and regulatory elements.
The plasmids were transfonned into Escherichia coli JMI09 and screened by ampicillin
resistence and agarose gel electrophoresis. The plasmids containing the desired promoter
region were finally confmned by sequencing with a Applied Biosystems 373A DNA
Sequencer in two directions from both ends of the desired promoter region using the same
primers as that for PeR.
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The transfonned JMI09 cells, which propagate plasmids at high copy numbers,
grew in LB medium for about 18 hours. The plasmid DNAs were isolated originally by
alkaline lysis followed by PEG (polyethylene glycol) precipitation (74) to remove trace
amount of protein, but we found plasmids isolated in this way gave no expression at all.
Therefore we changed the purification method by banding the plasmids twice in CsCI-
ethidium bromide isopycnic gradients (75) to obtain the super coiled plasmid DNA. After
the banding, ethidium bromide was removed by extraction with butyl alcohol (saturated
with a equal volume ofTE buffer containing 4M NaCI) 7-8 times. esCI was removed by
precipitation using 7.5 M ammonium acetate and ethanol 5 times. The purified plasmid
DNAs were stored in H20. The DNA concentrations were detennined by measuring their
absorbences at 260 om. The plasmid purity was detennined by their ratio of A2601A280,
spectrum scanning from 200 run to 320 nm, and restriction digestion.
Isolation and Culture of Primae' Hepatocytes
Primary hepatocytes were isolated from male Wistar rats (weight 200-250 g) liver
which was frrst perfused with collagenase (40 mg of Worthington type II Lot #F3B517) in
Krebs-Ringer Bicarbonate media without calcium (KRB without calcium, 200 ml of 0.15
M NaCI, 8 ml of 0.15 M KCI, 1.5 ml of 0.15 M KH2P04, 1.5 ml of 0.15 M
MgS04·7H20, 42 ml of 0.15 M NaHC03, 0.1 ml of 400 mg/ml streptomycin sulfate, pH
7.4) approximately 20 minutes under 5% C02, 95% 02 at 37 °C followed by KRB wash
and centrifugation to remove dead cells and other debris. Cell viability was determined by
cell appearances under microscope. The isolated cells were resuspended in incubation
media and plated at a initial density of 7.5 x lOS celVml in 60-mm tissue culture dishes
(Falcon) coated with rat-tail collagen (Table 3-1). After a 4-hour attachment period in
incubation medium (Table 3-2), the medium in the plates were replaced with Waymouth's
medium and incubated for another 18-24 hours, then transfection was started in SUM
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medium (Table 3-2) without antibiotics and incubated for 16-18 hours. Cells were then
washed with KRB (Table 3-1) once and maintained for the remainder of the culture time in
KRB media. Experimental compounds were added after cell wash, and 24 hours later, the
experiment was tenninated by removing the media from the plates and putting them in the
freezer.
lransfectiQD
For each 60-mm culture dish, 1.9-2.0 Jlg of DNA sample was added into 100 JlI of
SUM without antibiotics, and 12 JlI of lipofectin (Gibco) was added into another 100 Jll of
SUM without antibiotics, then the DNNSUM was put into the lipofectin/SUM and mixed.
After 20 min. setting at room temperature the mixture was added dropwise into a 60 mm
dish of cell culture.
Luciferase Assay
To prepare the Luciferase Assay Reagent, 10 ml of Luciferase Assay Buffer
(Promega) were added to the vial containing the lyophilized Luciferase Assay Substrate.
Cell Culture Lysis Buffer (promega) was prepared by adding 4 volumes of water were
added to 1 volume of Cell Culture Lysis 5X Reagent to produce a IX solution. Both the
diluted Lysis IX Reagent and an aliquot of Luciferase Assay Reagent were equilibrated to
room temperature.
Four hundred J..lI of Lysis IX reagent was added into each of the frozen cell dishes
to cover the cells and incubated at room temperature for 15 minutes. The lysed cells were
scraped off the dish and the cell lysate were transferred to a microcentrifuge tube and spun
briefly to pellet large debris.
The relative light units were recorded and integrated on a M3000 luminometer after
mixing 40 fJl of cell extract with 100 JlI of Luciferase Assay Reagent at room temperature.
Table 3-1
Compositions of coating solution and experimental media.
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KRB Collagen coating
Stock solution medium (1 liter) solution (500 00)
0.9 % NaCI 750 ml 411.2 ml
1.3 % NaHC03 157.5 ml 78.8 00
1.15 % KCI 30 ml ---
1.62 % CaC12*2H20 11.25 ml ---
2.11 % KH2P04 7.5 00 ---
3.82 % MgS04*7H20 7.5 ml ---
Streptomycin (400 mglml) 250 Jll 625 JlI
Amino Acid solution (Gibco) 20 ml ---
Ampicillin 60 mg ---
BSA 2000 mg ---
Rat-tail collagen stock --- 7.5 ml
Adjust pH to 7.0-7.1 and filter sterile.
Table 3-2
Compositions of cell culture and transfection media
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Incubation SUM
Stock solution medium (1 liter) medium (1 liter)
Minimum Essential Medium (Sigma) 750 ml 750 ml
Waymouth (Gibco) 250 ml 250 ml
Ampicillin 60 mg ---
Streptomycin (400 mglml) 250 III ---
Amphotericin B 250 JlI ---
Glutamine 292 mg ---
BSA 2000 mg ---
Alanine 40 mg 40 mg
Serine 52.6 mg 52.6 mg
NaHC03 2240 mg 2240 mg
Selenium (3 x 10-5 M) --- Iml
3,5,3' triiodo-L-thyronine (2.50 mglml) --- 673 III
Dexamethasone --- 0.788 mg




Stock solutions were prepared by dissolving 1 mg of crystalline porcine zinc insulin
(Lilly Research Laboratories) in 1 ml of 1 mM Hel, and the concentration were determined
spectrophotometrically at 276 om using A 0.1 % =1.05. Stock solutions were stored at 4
°C. Aliquots of the stock were further diluted as required in media containing bovine
serum albumin.
Vanadate Solution
Purified grade Na3V04 (Fisher Scientific) was used in all experiments. A 0.1 M
stock solution was prepared by dissolving powder in 0.1 M HEPES buffer (pH 7.2). The
pH of the solution was adjusted to 10 with 5 N NaOH, which gave a colorless solution.
The fmal concentration of vanadate solution was verified by measurement of absorbance at
260 nm using an extinction coefficient of 3.55 x 103 M-1cm-1 and a 0.1 N of NaOH
solution as blank. It was reported that at this pH vanadate is predominantly monomeric
HV04-2 (29). Immediately before each experiment an aliquot of a freshly prepared stock
was diluted as required in media containing bovine serum albumin.
CHAPTER IV
RESULTS AND DISCUSSION
Construction of Chimeric Genes
To test the response regions to glucose7 insulin and vanadate, the chimeric genes
containing a series of L-PK promoter deletion regions were made. The vector DNA was
pGL2-Basic plasmid (commercially from Promega) with luciferase marker, which is
promoterless and enhancerless. A 5'-flanking segment E (-70 to +10 bp relative to the L-
PK cap site) (Fig. 4-1) of the PK gene containing TATA box for L-type was inserted
upstream of the luciferase gene to create pGL-E (Fig. 4-2). Similarly, pGL-F, pGL-G,
pGL-H, pGL-I, pGL-J and pGL-K were created by inserting these fragments upstream of
the luciferase gene, respectively. pGL-R was obtained by multiplying and purifying pGL-
RegS, which was prepared by Raul Espinosa-Nava (unpublished), therefore pGL-R and
pOL-RegS are structurally identical. Fragment F (-101 to +10 bp) consisted of fragment E
and one of the three liver-specific expression elements (67, 68). Fragment G and F were
from -121 to +10 bp, -145 to +10 hp, respectively. Fragment I (-171 to +10) was
composed of fragment E through H and all the three liver-specific expression elements.
Fragment J (-503 to +10) contained the first exon of R-type isozyme and fragment I.
Fragment R (-1028 to +10) included CAT box for R-PK as well as fragment J. Fragment
K (-3113 to +10) had almost the whole promoter region of L- and R-type pyruvate kinase
including a putative cAMP regulatory element. These plasmids were propagated in E. coli
1M 109 and purified by alkaline denaturing and CsQ-ethidium bromide gradient centrifuge.
The DNA concentration was quantitated after resuspension in sterile H20 using a
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Locations of a series of deletion fragment in the promoter region of L.type pyruvate kinase. E, F, Ot H, I, J,
R and K are the fragments with different length from L-PK promoter region. These fragments were used for the construction of
chimeric genes. Each of the fragments has Hind III restriction site at 5' end and Bgl II restriction site at 3' end. cAMP,
regulatory element for adenosine 3', 5'-cyclic monophosphate found in the phosphoenolpyruvate carboxykinase gene; Glucort.,
the sequence homologous to the glucorticoid receptor binding site for DNA; CAT (R), CAT box for R-PK; Exon (R), the first
exon of R-PK in the pyruvate kinase gene; eRE, carbohydrate response elements; LI, L2 and L3, liver-specific expression
elements; TATA (L), tata box for L-PK; Exon (L), the frrst exon of L-PK in the gene; ATG, start codon for L-PK. The plot is
not in scale. The references are in the text ~l.Ia
Fig. 4-2
Construction of chimeric genes with a series of deletion region of L-PK.
Panel A: Vector DNAs of plasmid pGL2-Basic (from Promega) were first digested with
restriction enzymes of Hind III and Bgl II. After treatment of calf intestinal alkaline
phosphatase, inserted fragments were ligated respectively into the vector by T4 ligase.
Panel B is chimeric gene. The numbered positions are relative to the cap site of L-PK.
Panel C is a positive control plasmid of pGL-SV40 (pGL-2 promoter, commercially from
Promega). on, origin of plasmid replication in E. coli; fl on, origin of replication derived
from filamentous phage; SV40 promoter, region of DNA from SV40 virus early promoter;































Construction of chimeric genes with a series of deletion region of
L-PK.
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scanning (Fig. 4-3), restriction digestion and agarose gel electrophoresis to test their
qualities (Fig. 4-4). The ratio of A26Q/A280 (absorbances at 260 om and 280 nm) of these
samples were greater than 1.85. The scanning spectrums from 200 to 320 om indicated no
impurities in the samples. Gel electrophoresis showed that the major amount of the sample
DNAs were supercoiled plasmids and they were very sensitive to restriction digestions.
Finally, each of these samples were partly sequenced using previous peR primer
from both 3'_ and 51-end, respectively. The sequences were aligned to the published
sequence of pyruvate kinase in GeneBank database (58). The sequences agreed within 98
% of the published sequence (Fig. 4-5). As predicted by restriction sites, orientation of the
promoter regions were reversed at the site of transcription initiation from that projected for
the native PK gene promoter.
Optimization of lransfection
Since transfection efficiency is very important to gene expression experiments, we
tested two transfection protocols and a series of mass ratios of lipofectin (transfection
reagent) : DNA for selective samples. In protocol 1 which was employed by Mr.Chris
Otiko (81), the cultured cells were washed twice with phosphate buffered saline after 4-
hour attachment phase and then were transfected in SUM medium. In protocol 2, the cell
culture medium was replaced with Waymouth's medium and incubated for 18-24 hours
after 4-hour attachment period, and then the cells were washed twice with SUM medium
and the transfection was carried out in SUM medium. The difference between Protocol 1
and Protocol 2 is an additional 18- to 24-hour incubation in Waymouth's medium after 4-
hour cell attachment, which might partially recover the cell functions after isolation. The
expression units (light units in 60 seconds) dramatically increased under Protocol 2 (Fig.4-
6). Fig.4-7 shows the luciferase activities after different amount of DNA while keeping














UV light scanning spectra of chimeric gene pGL.I, pGL.J, pGL.K,
pGL.R and pGL.RegS. The DNAs were dissolved in H20. The peak of pGL-
Reg5 prepared by Raul Espinosa-Nava was slightly less than that of the others.
Fig. 4-4
Electrophoresis analyses of plasmid pGL.E through pGL.K on agarose gel.
Panel A: E, F, 0, H, I, I, K and R represented plasmid pGL-E to pGL-R. These plasmids
were obtained by Alkaline denature followed by PEG precipitation and used for
sequencing. The amount of DNA loaded in each well of 0.75 % agarose was about 40 ng.
The samples were run in Ix TAE buffer, 100 volts for 1 hour at 4 ·C. Panel B: E, F, 0,
H, I, I, R, K and Std. represented plasmid pGL-E through pGL-K and standard of high
molecular weight DNA. These plasmids were purified by CsCl-ethidium bromide binding
and used for the remaining experiments. Each plasmid in the right lane was digested by
restriction enzyme of Hind III (,.., 1 U/J.1.g DNA) for 2.5 hours, the left was not digested.
Other conditions were the same in Panel A. Panel C: The left lanes were the plasmids,
which were the same as those described in Panel B, digested by restriction enzymes of
Hind III and Bgl II (~1 U/Jlg DNA for each enzyme). The samples in the right lanes were
the corresponding fragment products directly from peR. The conditions of electrophoresis
































Electrophoresis analyses of plasmid pGL-E through pGL.K on
agarose gel.
Fig. 4-5
Sequences of Fragment E, F, G, H, I, J and partial sequences or Fragment Rand K. Panel A are the sequences
from both the 3'- and 5'-end, except K and R, using the previous PCR primer. Panel B are the sequences of K and R from the
5'-end using the previous peR primer containing Hind III site. These fragment sequences were aligned to the published L-PK
sequences. The published sequences are underlined. The errors of bases are boxed. lSI, unidentified bases; Luc, luciferase
gene; Hind In, Hind HI site. The numbers in the sequences are relative to the L-PK mRNA cap site.































GATCTTTAGG TCCCAAAAAG ACTTGQCAAA GTCTGCCTTA AGTGGGGCTC CCGGAGGTAA GAAGAGGAAG
GATCTTTAGG TCCCAAAAAG ACTTGGCAAA GTCTGCCTTA AAGTGG~TC CCGGAGGTAA GAAGAGGAAG
GAT~AGG TC~AAAAAG ACTTGGCAAA GTC~CCTTA AGTGGGGCTC CCGGAGGTAA GAAGAGGAAG


















GTAGAATCAG CGTTGAGAGA TGGAQGCCTT GTGGGGTAGG
GTAGAATCAG CGTTGAGAGA TGGAGGCCTT GTGGGGTAGG
GTAGAATC~ CGTTGAGAGA TGGAGGCCTT GTGGGGTAGA





TAGCCTCACC TCGGCTAAAT ACAGACCTGA TCTGAGCCIT
TAGCCTCACC TCGGCTAAAT ACAGACCTGA TCTGAGCCTT
TAGCCTCACC TCGGCTAAAT AC~ACCTGA TCTGAGCCTT


























H: C TGGACTCTGG CCCCCAGTGT


























































































































• -3109 -3014 •
5' •.. ATAGAG AGTGTCCTCT GGTAGGAGCA TGTGCXCAGC TTACTCCTCA CCCAQTCTCC CACOGGTaCT ATTccceACT GACeAAAeTC TGTGGAAGCC
It: ------Primer------ GGTAGGAGCA TGTGATCAGC 'M'ACTCCTCA CCCAGTCTCC CACGGGTGCT ATTCCCCACT GACCAAACTC 'roTGGAAGCC
• -3013 -2914 *
CTGGGACAAA GCCTTIGGCT CC'M'QCCCCA MTCAGAGM GAAGGGGCCA GAGACAGGGT CTGGAGTGAC CCCAGATGCA TGGCACACTC TCCTCMCTC
It: CTGGGACAAA GCCT'M'GGCT CCTTGCCCCA AATCAGAGM GAAGGGGCCA GAGACAGGGT CTGGAGTGAC CCCAGATGCA TGGNACACTC TCCTCAACTC
* -2913 -2814 •
CCTGGGGCCT CCTGTCAGGA CAGGMAGCA AAAGCATGCC CAGCTGTCAG TCCTGGATTT TMTGATTAA CTGGCACTTC AAACACMCC TGTGCCMAC
It: CcroGGG,tCT CCTGTCAGGA CAGGAAAGCA AAAGCATGCC CAGCTGTCAG TCCTGGArrwfT TAATGATTAA CTGGCACTTC AAACACAGCC TGroCCAAAC
* -2813 -2714 •
AGGAGTCTTG GATTeeAeeA TCTTrITTCT TTCTnCTTT TCTTrC'ITTC TTTTTTTTTT TTGATATTTT TATTTACATT TCAAATGTTA TTCCCTTCCC
It: AGGAGTCTTG GATTCCACCA TCT'ITIfD:T 'IfJ:TTTCTTT TCM'TCTTTC~ TTGATA'M''M' TATTTACATT TCAAA'roTTA TTCCCTTCCC
• -2713 -2614 •
CGGTTrCCCT TTCTATGAGG ATGTTCCCCC TeeeeAAeeA eeeeeCATTe CTGeCIeTeT CTCTeTeTCT CTCTeTeTCT CACACACACA CACACACACA
K: CGGTTTCCCT TTCTATGAGG ATGTTCCCCC TCCCCAACCA CCCCCCA'!O: croCCTCTCT CTeTCTCTCT CTCTCTeTCT CACACACACA CACACACACA
CACACAeACA CACACACACA ... 3'
Jt: CACACACACA CACAC • -2594
• -1024 -929 •
5 ' ... TATGAT CTeCCTGGTG AGATCGATGC CCTTGTGATG GCTGAGGAGA TCCCCTGTAC TCAGGTTTCC ATGTG'ITTAT CCATACGGCT GGTCAACAAC
R: -------Primer----- AGATCGATGC CCTTGHGATG GCTGAGGAGA TCCCCTGTAC TCAc8rTTCC ATGTGTTTAT CCATACGGCT GGTCAACAAC
* -928 -829 •
MTACAAGTT TATGAGTTAG TGCCTAGGAA TGTTCATGGT TTCATCTCTG GGTTCTCAGA GGMCATGTG CGAGAMCTG AGAGACCCTC TAACCT'M'M
R: AATACAAGTT TATGAGTTAG TGCCTAGGAA TGTTCATGGT 'rrcATCTCTG GG'M'CTCAGA GGAACATGTG CGAGAAACTG AGAGACCCTC TAACCTI'TAA
* -828 -729 *
CTACCAMGG GTATCCCTGT TTTCCACAGC CTAQTeCCCA CCneMaCT CTTG'M'eTGA GAATACACCT MGATTCTCT TCAATAMAT GCAAAQAQAA
R: CTAcc1fD\GG GTATCCCTGT TTTCCACAGe CTAGTCCCCA CCTTCMGCT CTTGTTCTGA GAATACACCT AAGATTCTCT TCAATMA'AT GCAAAGAGAA
• -728 -639 *
AGGCA'l=rGTA CTGTroGCM TCAAceAATC TCTTCTCTAA TGATGAGCCA ACMTGTGAA TGGACTAATG ATTGATCAGG AMAMTAGA ... 3 1





gave reasonably high expression. Thus a mass ratio of lipofectin : DNA of 6 :1 was
chosen for these preparations and no morphological toxicity was observed during the
experimental period. For pGL-SV40 (pGL2-promoter, purchased from Promega) and
pGL-RegS, no peaks appeared on the curve, which meant that their optimal expressions
were beyond the testing range. Considering the other plasmid samples, we chose 2 Jlg of
each for the remaining experiments.
A linearity test was always carried out using purified luciferase protein in each
experiment to detennine if light units produced fell within the proportional range in the
luciferase assay.
Expression of Chimeric eenes
To test the expressions of the chimeric genes containing L-PK promoter sequences,
the plasmid constructs were introduced into primary hepatocytes. After 18- to 24-h
incubation in SUM medium without antibiotics, the transfected cells were washed twice
and cultured in KRB medium, and the experimental compounds were added as indicated.
The expressions under desired conditions last 16-18 hours and then the cell extracts
were assayed for luciferase activity by measuring the light units produced after addition of
substrates of luciferin and ATP. The negative control was pGL2-Basic plasmid vector
itself, which is promoterless and enhancerless. The positive control was pGL-SV40
(Promega) (Fig. 4-2) which has SV40 early promoter upstream of the luciferase reporter
gene. The quality or internal control was pGL-Reg5, which allowed us to compare the
current results to previous results in our laboratory.
Since a large number of plates were needed due to seven constructs and three
control plasmids all in triplicate, we were unable to test all plasmids in one experiment.
Table 4-1 showed two individual experiments data from triplicate samples and the average
activities of replicate experiments are summarized in Fig. 4-8. The magnitude of induction
Fig. 4-6
Luciferase activities of pGL-Reg5 and pGL-SV40 in different transfection
protocols and different mass ratios of DNA : lipofectin. In Protocol 1, the
cultured cells were transfected with pGL-RegS and pGL-SV40 after 4-h cell attachment
phase. In Protocol 2, the cultured cells were transfected with pOL-Reg5 and pGL-SV40
after 4-h cell attachment phase and a 18- to 24-h additional incubation in Waymouth's
medium. All transfections were carried out at constant amount of 12 Jlg lipofectin with
indicated amount of DNA. The luciferase activities were detennined by light units
























































Amount of DNA (JJg)
Fig. 4-6
Fig. 4-7
Luciferase activities of pGL-F, pGL-H, pGL-J and pGL.K under different
mass ratios of DNA: lipofectin in Protocol 2. All transfections were carried out
at constant amount of 12 Jlg lipofectin with indicated amount of DNA. The luciferase
activities were detennined by light units produced in 60 seconds.
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Modulation of L-type pyruvate kinase gene expression in isolated
bepatocytes by glucose, vanadate and insulin (Iuciferase assay) D
represent mean ± S.E. (light units x 10-3) of two separate experiments in triplicate.
Numbers with the same letter are not significantly different. P-values for all experiments
presented were < 0.01 except pGL-K which was 0.034. Numbers in parentheses represent




Modulation of L.type pyruvate kinase gene expression in isolated rat
hepatocytes by glucose, vanadate and insulin (Iuciferase assay) (LV x 10-3)
5mM 20mM 5 mMGlucose 5 mM Glucose
Plasmid Glucose Glucose 10-7 M Insulin 1.5 IJM Vanadale
(Experiment 1):
pGL2-Basic O.O3±O.OO 1.16±O.11 -~~..... ------
22.9c±I.28 46.6a±3.00 33.7b±3.04 26.sbc±o.30
pGL-SV40 (100) (203) (147) (115)
o.4ob±o.06 O.82a±O.06 O.48b±o.04 O.35b±o.03
pGL-E (100) (204) (120) (88)
19.7bc±1.35 43.7a±1.09 33.ob±3.0 25.2c±0.88
pGL-F (100) (147) (111) (85)
288b±10.2 485a±5.24 299b±14.4 236c±7.0
pGL-H (100) (169) (104) (82)
20.4b±1.31 51.3a±3.37 25.ob±I.91 25.2b±o.94
pGL-RegS (100) (251) (122) (123)
(Experiment 2):
pGL2-Basic O.OO±O.OO O.OO±O.OO ------ ---_..-
0.31 b±O.14 1.56a±O.23 O.58b±o.07 o.2ob±o.07
pGL-SV40 (100) (506) (186) (64)
13.6b±o.69 24.3a±1.31 15.4b±2.52 12.8b±o.19
pGL-G (100) (179) (113) (94)
28.3b±o.69 46.1 a±I.96 31.1b±I.84 20.6c±3.67
pGL-I (100) (163) (110) (73)
29.8b±2.41 58.0a±3.78 21.3b±1.16 27.4b±3.47
pGL-J (100) (194) (71) (92)
6.20c±O.69 lO.9a±O.51 10.7ab±1.58 7.27bc±1.23
pGL-K (100) (176) (172) (117)
91.4b±9.51 190a±10.8 88.ob±9.24 82.9b±15.9
pGL-R (100) (207) (96) (91)
2.58b±o.11 5.35a±1.40 1.1Sb±o.32 2.50b±o.34
pGL-Reg5 (100) (208) (45) (97)
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varied between hepatocyte preparations. All data were statistically subjected to ~~Analysis
of Variance" on SAS/STATTM program (SAS Institute Inc. Cary, Ne, USA; 1985,
Version 6).
From Table 4-1, the expression of pGL-E was very low and we did not repeat
pGL-E any more. The other constructs all expressed very well and responded to glucose.
These results agreed with the work of Towle et al (73). The data from Table 4-1 and
Fig.4-8 suggest that although pGL-K contains all necessary elements for expression, its
activity was the lowest perhaps suggesting the presence of a silencer element.
The luciferase activities from the constructs pGL-F, pGL-G, pGL-H, pGL-I, pGL-
J, pGL-R and pGL-K increased markedly when concentrations of glucose were elevated
from 5 mM to 20 mM. Expressions could be observed under only glucose alone without
insulin or insulin-mimic reagent vanadate, which did not agree with Decaux (69) and
Munnich (71) observations who showed glucose and insulin together needed for increased
mRNA levels in pyruvate kinase in culture rat liver cells.
Statistical data indicated that there were no physiologically different effects from
insulin and vanadate in this research.
Treatment with 10-7 M insulin and 5 mM glucose, or with 1.5 JlM vanadate and 5
mM glucose did not significantly stimulate the gene expressions, which was not consistent
with Mr.Chris Otiko's results (2) who got marked effects of vanadate or insulin on pGL-
RegS expression. To test if the effects of insulin and vanadate on the gene expression are
protocol-dependent, the gene expression of pGL-Reg5 was caried out in Mr. Christ Otiko's
protocol (2) and the results are shown in Fig. 4-9. The results were obtained from one
experiment in triplicate samples, which suggest that the expression of pOL-Reg5 in
response to glucose, insulin and vanadate was influenced by manipulation of cell culture
conditions.
Fig. 4-8
The effects of glucose, insulin and vanadate on gene expression of L.type pyruvate kinase. The rat
hepatocytes were transfected with control plasmid pGL-SV40 and chimeric gene pGL-F through pOL-Reg5 which contained
segments of the L-PK promoter deletion regions, respectively. These transfected cells were expressed under indicated conditions
in KRB medium. The expression activities were measured by light units produced in 60 seconds. The results are presented as a
percentage relative to their corresponding construct under control condition of 5 mM glucose. These data were detennined from
averaging the results of at least two experiments with triplicate samples. The bars with * indicate the data significantly different
from their relevant control at 5 mM glucose (statistical analysis was carried out individually in each single experiment). Numbers















• 5 mM Glucose
• 20 mM Glucose
• 5 mM Glucose + 0.1 jJM Insulin












The transfection and expression of chimeric gene in different protocols.
The transfection and expression of pGL-Reg5 were carried out by using different
protocols. The data of pOL-Reg5 with standard error bars in the figure represent the
results obtained from the present protocol, in which the transfection was carried out under
protocol 2 described in the text, and the transfected cells were expressed under indicated
conditions in KRB medium, by duplicate samples. The data of pGL-Reg5* with standard
error bars in the figure represent the results obtained from Chris Dtiko' s protocol, in which
the uansfection of pOL-Reg5 was carried out under protocol 1 described in the text, and
the transfected cells were expressed under indicated conditions in SUM medium, by
triplicate samples. The expression activities were measured by light units produced in 60
~econds. The results are presented as a percentage of the corresponding construct under
control condition of 5 mM glucose and none respectively. These data were detennined
from a single experiment. T, standard error bar. The bars with * are significantly
different from their corresponding controls.
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Lipofectin-mediated DNA transfection is a simple and effective technique for
studying gene expression in a variety of cell lines. This method would facilitate studies to
directly compare the relative strengths of different promoters. It was reported to be from 5-
to tOO-fold more effective than either the calcium phosphate or the DEAE-dextran technique
(76, 77). Constructs in which albumin, PEPCK and L-PK promoters were linked to a
CAT gene all can be expressed after lipofection into primary hepatocytes, and the PEPCK
promoter exhibits appropriate honnonal control (73, 78).This indicates that liver-specific
transcription is not disrupted by this method. However, a ratio of lipofectin : DNA is very
important in this technique. Optimization of the ratio is necessary for every batch
preparation and individual samples. In this research, although the purification method for
pGL-E through pGL-K was changed from PEG precipitation to CsCI-ethidium bromide
gradient binding, these chimeric genes did not express any more at the ratio of 4 :1 at which
pOL-Reg5 expressed very well in Mr. Chris Otiko's studies (2), but the same samples of
pOL-E to pGL-K highly expressed at the mass ratio of lipofectin : DNA of about 6 : 1 that
is closed to 6.67 : 1 reported by Katherine (78) and Jacoby (79).
Lipofectin is a liposome comprised of a positively charged lipid. The postulated
mechanism of action for the liposomes is that sonicated lipid vesicles in water fonn
spontaneously DNA-lipofectin complexes by interaction between positive and negative
charge after mixing an aliquot of the reagent with an aqueous solution of DNA, trapping
nearly all of the polynucleotide in the complex interior (80) and then these complexes fused
to cell membrane and delivered the polynucleotides into the cells. If the ratio of liposome :
polynucleotide is not appropriate, it might affect the liposomes, completely trapping DNA
(if less) or blocked the wrapped DNA delivery (if more). This would bring about large
variability and even result in no expression ultimately.
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Since complexes of DNA-lipofectin are formed by charge-charge interaction. some
chemicals involved in DNA preparations may interfere with transfection. The most known
interfering compound is EDTA. The chimeric genes purified by PEG defmitely did not
express even though these samples behaved very well in agarose gel electrophoresis,
restriction digestion, sequencing and etc. perhaps some impurity existied in the chemicals.
Of course we should have optimized the ratio for this batch preparation to confmn if no
expression from this preparation resulted from the inappropriate ratio of 4: 1 or PEG
interference. At the same conditions, pGL-R expressed always higher than pGL-Reg5
possibly due to the reason that pGL-Reg5 was not in optimal ratio which are indicated in
Fig.4-6. The same was true for pGL-SV40. This might be why they have relatively large
standard errors (data not shown).
Luciferase as a reporter gene is sensitive, rapid and quantitative. It does not require
the use of radioactivity and allows many samples to be assayed in short time period.
However, variability likely arose in luciferase assay since luciferase and its substrates may
not be mixed well in a very small assay volume and very short assay period. It is reported
that (78) only a total of 5-10 % of the cells can be transfected, then the cells in the dish
seems to be excess. Therefore, the cell numbers in each culture plate were not critical for
the experiments. In fact, the expression units were not proportional to total number of cells
in the plate. Lower number of cells in the plate could also gave higher light units when
other conditions were the same in one experiment (data not shown). Of course, some
unknown and random factors can cause variability, for instance, if the transfected cells
were lost during several washes, these culture plates would give lower expression units.
As mentioned above, the data variability was mainly due to three things. First, the
mass ratio of lipofectin : DNA strongly affects transfection efficiency, but careful
optimizing the ratio would not be practical for multiple samples since it is time-wasting and
costly job. Second, luciferase assay may cause variations in light units produced by assay
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mixture. Finally, some unknown factors randomly influence the reproducability. These
limited us to parallely compare the expression strength of the regulatory region(s) to
carbohydrate, insulin and vanadate simultaneously. Of course, the standard errors from
each triplicate samples were under reasonable range (- 10 % of the mean)
We chose adult rat hepatoeytes in primary culture rather than hepatoma cell lines for
the studies because rat hepatocytes conserve a correct tissue-specific expression and
honnonal response (69). Why could we not repeat out Chris Otiko's results (2), in which
insulin and vanadate seemed to more directly stimulate pGL-Reg5 expression rather than a
"permissive" effect, with pGL-R and even pGL-Reg5 itself. One of the possible
explanations is that the insulin receptors on the cell surface were damaged during
collagenase perfusions. We did find that the collagenase from different lot numbers greatly
affected cell viability and morphology. In Fig.4-9, the gene expression of pOL-RegS was
markedly stimulated by vanadate and insulin, which suggests that the effects of vanadate
and insulin on the gene expression of pGL-RegS or other L-PK promoter constructs might
be protocol- or medium- dependent although I have not enough data to confirm this.
Because in Chris Otiko's procedure (2), transfections were carried out after 4-hour cell
attachment period when high concentration (10-7 M) of insulin was maintained, and the
transfected cells were expressed in SUM medium under indicated conditions, whereas we
perfonned transfections after 4-hour cell attachment phase when the cells were under 10-9
M insulin. and a 24-h additional incubation in Waymouth's medium, and the expression of
luciferase activities was going on in KRB medium. However, with careful analysis of the
compositions of SUM medium which was used for gene expression by Chris Otiko, I
found that SUM medium contains high basal level of glucose at about 10 mM, the
increased expression of pGL-RegS stimulated by vanadate and insulin alone might come
from the high basal level of glucose in the medium. In addition, the concentrations of
insulin and vanadate might not be high enough to significantly stimulatie these gene
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expression during my experiments because Bosch et al (43) claimed that the inhibitory
effect of vanadate was observed at concentrations of 0.5 mM or greater, the concentration
approximates the minimal levels of vanadate which activate the tyrosine kinase of the
insulin receptor. Based on our present results, it is hard to tell if the effects of vanadate and
insulin on the gene expression are protocol-dependent or that vanadate and insulin do not
directly affect the gene expression.
Although pGL-K contains all necessary elements for expression, its expressions
were lowest. It was possible that in reverse direction, the TATA box in the longest
promoter sequence was farthest from the report gene, which had the weakest actions on the
transcription of downstream luciferase. On the other hand, sequence at position -2338 to
-2328 is a cAMP regulatory element found in the phosphenolpyruvate carboxykinase gene
promoter region. Dexamethasone in SUM medium might antagonize stimulation of glucose
since Dexamethasone was reported to regulate gene expression perhaps via secondary
signal cAMP (81).
Table 4-1 showed that the activities of pGL-I and pGL-J were higher than pGL- G.
It could be explained that both pGL-I and pGL-J contain all three liver-specific expression
elements (Fig. 4-1) but pGL-G has only one of them, and these elements had synergistic
effect (67).
Surprisingly, the expressions of the positive control plasmid pGL-SV40 were
apparently stimulated by glucose and also slightly ncreased under addition of insulin or
vanadate in a similar way to the others. This suggests that glucose might universally
influence transcription of a certain kind of genes, or there might not be carbohydrate
response elements in specific region of L-PK promoter. Alternatively, glucose responses
may be present in the SV40 promoter.
CHAPTER V
SUMMARY AND CONCLUSION
1. The chimeric genes of pGL-F, pGL-G, pGL-H, pGL-I, pGL-J pGL-R and pGL-K
were highly expressed under our experimental conditions. They well responded to glucose
although their promoters were insened in the reversed direction. This indicated that the
carbohydrate regulatory elements in pyruvate kinase promoter are independent of
orientation.
2. Insulin and vanadate neither significantly stimulated the gene expressions nor
apparently exhibited discrete effects on those chimeric genes based on this research. The
stimulation of vanadate and insulin on the expression of these chimeric genes might be
protocol-dependent. That vanadate and insulin directly affect the gene expression or that
they only playa "pennissive role" in glucose for the gene expression remains unknown.
3 . The variability of lipofectin transfection limits its use on quantitative comparison of
expression strength from multiple gene constructs.
4 The positive control plasmid of pGL-SV40 responded very well to glucose. The
fashion of the response to glucose, insulin and vanadate was similar to that of the other
chimeric genes, which suggests that either there might not be carbohydrate-specific
element(s) (eRE) in the L-PK promoter or SV40 promoter contains the eRE.
5. We need to reverse the promoter direction in each deletion construct and further
locate the regulatory regions responded to insulin, vanadate and glucagon in future.
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